Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment

Published:2021-11-23 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Rottenberg Yakir¹²,Grinshpun Albert³,Ben-Dov Iddo Z.⁴²,Oiknine Djian Esther⁵²,Wolf Dana G.⁵²,Kadouri Luna¹²

Affiliation:

1. Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel

2. Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

3. Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

4. Department of Nephrology and Hypertension, Hadassah Medical Center, Jerusalem, Israel

5. Clinical Virology Unit, Department of Microbiology and Infectious Disease, Hadassah Medical Center, Jerusalem, Israel

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2786532/jamaoncology_rottenberg_2021_ld_210027_1637092169.8265.pdf

Reference6 articles.

1. COVID-19 severity and outcomes in patients with cancer: a matched cohort study.;Brar;J Clin Oncol,2020

2. Incidence of SARS-CoV-2 infection among patients undergoing active antitumor treatment in Italy.;Aschele;JAMA Oncol,2021

3. Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment.;Grinshpun;ESMO Open,2021

4. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.;Herishanu;Blood,2021

5. Protection of BNT162b2 vaccine booster against Covid-19 in Israel.;Bar-On;N Engl J Med,2021

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low booster uptake in cancer patients despite health benefits;iScience;2024-09

2. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study;Journal of Infection and Public Health;2024-07

3. The effect of COVID-19 on cancer immunotherapy and cancer care;Clinical Immuno-Oncology;2024

4. Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals;The Journal of Infectious Diseases;2023-11-16

5. Low booster uptake in cancer patients despite health benefits;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3